EdgarLookup

CERO THERAPEUTICS HOLDINGS, INC. — All Filings

419 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 25-NSE 3 3/A 4 4/A 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFM14A DEFR14A DRS EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRER14A S-1 S-1/A S-3 S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
3 — 0001213900-24-015018 Feb 16, 2024 Feb 14, 2024
3 — 0001213900-24-015017 Feb 16, 2024 Feb 14, 2024
3 — 0001213900-24-015016 Feb 16, 2024 Feb 14, 2024
3 — 0001213900-24-015015 Feb 16, 2024 Feb 14, 2024
8-K CURRENT REPORT 0001213900-24-014197 Feb 15, 2024 Feb 13, 2024
25-NSE — 0001354457-24-000075 Feb 14, 2024 —
425 8-K 0001213900-24-013807 Feb 14, 2024 —
8-K 8-K 0001213900-24-013804 Feb 14, 2024 Feb 13, 2024
425 CURRENT REPORT 0001213900-24-012582 Feb 12, 2024 —
8-K CURRENT REPORT 0001213900-24-012571 Feb 12, 2024 Feb 8, 2024
SC 13G/A FORM SC 13G/A 0001062993-24-002376 Feb 8, 2024 —
424B3 PROSPECTUS 0001213900-24-010236 Feb 6, 2024 —
425 CURRENT REPORT 0001213900-24-010231 Feb 6, 2024 —
8-K CURRENT REPORT 0001213900-24-010227 Feb 6, 2024 Feb 5, 2024
DEFM14A PROXY STATEMENT 0001213900-24-005378 Jan 22, 2024 —
424B3 PROSPECTUS 0001213900-24-005374 Jan 22, 2024 —
EFFECT — 9999999995-24-000155 Jan 19, 2024 —
CORRESP — 0001213900-24-004370 Jan 18, 2024 —
S-4/A REGISTRATION STATEMENT 0001213900-24-003847 Jan 17, 2024 —
S-4/A REGISTRATION STATEMENT 0001213900-24-002005 Jan 9, 2024 —
CORRESP — 0001213900-24-002007 Jan 8, 2024 —
425 CURRENT REPORT 0001213900-24-001517 Jan 5, 2024 —
8-K CURRENT REPORT 0001213900-24-001511 Jan 5, 2024 Jan 3, 2024
S-4/A AMENDMENT NO. 3 TO FORM S-4 0001213900-23-096240 Dec 18, 2023 —
CORRESP — 0001213900-23-096243 Dec 15, 2023 —
UPLOAD — 0000000000-23-013703 Dec 15, 2023 —
DEF 14A PROXY STATEMENT 0001213900-23-095749 Dec 14, 2023 Jan 3, 2024
CORRESP — 0001213900-23-095295 Dec 13, 2023 —
425 CURRENT REPORT 0001213900-23-094786 Dec 11, 2023 —
8-K CURRENT REPORT 0001213900-23-094779 Dec 11, 2023 Dec 8, 2023
CORRESP — 0001213900-23-094707 Dec 11, 2023 —
CORRESP — 0001213900-23-093399 Dec 6, 2023 —
PRE 14A PROXY STATEMENT 0001213900-23-090212 Nov 27, 2023 —
10-Q QUARTERLY REPORT 0001213900-23-085200 Nov 9, 2023 Sep 30, 2023
425 CURRENT REPORT 0001213900-23-075420 Sep 8, 2023 —
8-K CURRENT REPORT 0001213900-23-075416 Sep 8, 2023 Sep 7, 2023
UPLOAD — 0000000000-23-009359 Aug 24, 2023 —
10-Q QUARTERLY REPORT 0001213900-23-066987 Aug 14, 2023 Jun 30, 2023
425 CURRENT REPORT 0001213900-23-066379 Aug 14, 2023 —
8-K CURRENT REPORT 0001213900-23-066376 Aug 14, 2023 Aug 11, 2023
S-4/A REGISTRATION STATEMENT 0001213900-23-066368 Aug 14, 2023 —
CORRESP — 0001213900-23-066371 Aug 11, 2023 —
UPLOAD — 0000000000-23-008330 Aug 2, 2023 —
CORRESP — 0001213900-23-058047 Jul 19, 2023 —
S-4/A REGISTRATION STATEMENT 0001213900-23-058043 Jul 19, 2023 —
425 AMENDMENT NO. 1 TO FORM 8-K 0001213900-23-057849 Jul 18, 2023 —
8-K/A AMENDMENT NO. 1 TO FORM 8-K 0001213900-23-057845 Jul 18, 2023 Jul 7, 2023
425 CURRENT REPORT 0001213900-23-055878 Jul 10, 2023 —
8-K CURRENT REPORT 0001213900-23-055873 Jul 10, 2023 Jul 7, 2023
UPLOAD — 0000000000-23-007158 Jul 5, 2023 —